Old Web
English
Sign In
Acemap
>
authorDetail
>
M Tan
M Tan
Bristol-Myers Squibb
Urology
Nivolumab
Intensive care medicine
Renal cell carcinoma
Pathology
1
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cost Utility Analysis (CUA) of Nivolumab Compared To Everolimus for The Treatment of Metastatic Renal Cell Carcinoma (RCC) in Australia
2017
Value in Health
Danny Liew
N Patten
M Tan
Hansoo Kim
Show All
Source
Cite
Save
Citations (0)
1